Cargando…

Structural diversity of the SARS-CoV-2 Omicron spike

Aided by extensive spike protein mutation, the SARS-CoV-2 Omicron variant overtook the previously dominant Delta variant. Spike conformation plays an essential role in SARS-CoV-2 evolution via changes in receptor-binding domain (RBD) and neutralizing antibody epitope presentation, affecting virus tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gobeil, Sophie M.-C., Henderson, Rory, Stalls, Victoria, Janowska, Katarzyna, Huang, Xiao, May, Aaron, Speakman, Micah, Beaudoin, Esther, Manne, Kartik, Li, Dapeng, Parks, Rob, Barr, Maggie, Deyton, Margaret, Martin, Mitchell, Mansouri, Katayoun, Edwards, Robert J., Eaton, Amanda, Montefiori, David C., Sempowski, Gregory D., Saunders, Kevin O., Wiehe, Kevin, Williams, Wilton, Korber, Bette, Haynes, Barton F., Acharya, Priyamvada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947964/ https://www.ncbi.nlm.nih.gov/pubmed/35447081 http://dx.doi.org/10.1016/j.molcel.2022.03.028

Ejemplares similares

Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity
por: Gobeil, Sophie M.-C., et al.
Publicado: (2021)

Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike
por: Stalls, Victoria, et al.
Publicado: (2022)

Cold sensitivity of the SARS-CoV-2 spike ectodomain
por: Edwards, Robert J, et al.
Publicado: (2021)

D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction
por: Gobeil, Sophie M.-C., et al.
Publicado: (2021)

Controlling the SARS-CoV-2 spike glycoprotein conformation
por: Henderson, Rory, et al.
Publicado: (2020)

Controlling the SARS-CoV-2 Spike Glycoprotein Conformation
por: Henderson, Rory, et al.
Publicado: (2020)

Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage
por: Henderson, Rory, et al.
Publicado: (2023)

Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation
por: Henderson, Rory, et al.
Publicado: (2020)

A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice
por: Martinez, David R., et al.
Publicado: (2021)

Network analysis uncovers the communication structure of SARS-CoV-2 spike protein identifying sites for immunogen design
por: Manrique, Pedro D., et al.
Publicado: (2022)

Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
por: Sempowski, Gregory D., et al.
Publicado: (2020)

Transient transfection and purification of SARS-CoV-2 spike protein from mammalian cells
por: Stalls, Victoria, et al.
Publicado: (2022)

Structure-Based Stabilization of SOSIP Env Enhances Recombinant Ectodomain Durability and Yield
por: Wrapp, Daniel, et al.
Publicado: (2023)

Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice
por: Mu, Zekun, et al.
Publicado: (2022)

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
por: Li, Dapeng, et al.
Publicado: (2021)

Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Ability of nucleoside-modified mRNA to encode HIV-1 envelope trimer nanoparticles
por: Mu, Zekun, et al.
Publicado: (2021)

Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
por: Weissman, Drew, et al.
Publicado: (2021)

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
por: Haynes, Barton F., et al.
Publicado: (2022)

Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers
por: Nyanhete, Tinashe E., et al.
Publicado: (2021)

A single, continuous metric to define tiered serum neutralization potency against HIV
por: Hraber, Peter, et al.
Publicado: (2018)

Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
por: Han, Qifeng, et al.
Publicado: (2019)

Identification of CDRH3 loops in the B cell receptor repertoire that can be engaged by candidate immunogens
por: Swanson, Olivia, et al.
Publicado: (2023)

Disruption of the HIV-1 Envelope allosteric network blocks CD4-induced rearrangements
por: Henderson, Rory, et al.
Publicado: (2020)

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
por: Shen, Xiaoying, et al.
Publicado: (2021)

The SARS-CoV-2 Spike variant D614G favors an open conformational state
por: Mansbach, Rachael A., et al.
Publicado: (2021)

Microsecond dynamics control the HIV-1 envelope conformation
por: Bennett, Ashley L., et al.
Publicado: (2023)

An Antibody from Single Human V(H)-rearranging Mouse Neutralizes All SARS-CoV-2 Variants Through BA.5 by Inhibiting Membrane Fusion
por: Luo, Sai, et al.
Publicado: (2022)

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines
por: Shen, Xiaoying, et al.
Publicado: (2021)

The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State
por: Mansbach, Rachael A., et al.
Publicado: (2021)

Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies
por: Henderson, Rory, et al.
Publicado: (2019)

Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates
por: Cai, Fangping, et al.
Publicado: (2021)

Coping with Viral Diversity in HIV Vaccine Design: A Response to Nickle et al
por: Fischer, Will, et al.
Publicado: (2008)

T cell-based strategies for HIV-1 vaccines
por: Korber, Bette, et al.
Publicado: (2019)

Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
por: Haynes, Barton F., et al.
Publicado: (2023)

RAB11FIP5-Deficient Mice Exhibit Cytokine-Related Transcriptomic Signatures
por: Li, Dapeng, et al.
Publicado: (2020)

ARMADiLLO: a web server for analyzing antibody mutation probabilities
por: Martin Beem, Joshua S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nv8n9o0ub42p2sf40cak96n3gl